ArticleAnnals of translational medicine2021

Pathological complete response after neoadjuvant treatment determines survival in esophageal squamous cell carcinoma patients (NEOCRTEC5010).

Jianfei Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.